Pharmaceuticals
Most popular vitamin, mineral supplements provide no health benefit, study finds
31 May 2018
A new study suggests most common vitamin and mineral supplements have no consistent benefit for the prevention of cardiovascular disease, heart attack, stroke or premature death
Aurobindo and others in the race to buy Novartis portfolio of US assets
12 May 2018
If Aurobindo Pharma is successful in clinching the deal, it would be the largest acquisition of an overseas business by any Indian drug producer, after Lupin's 2015 acquisitions of Gavis Pharmaceuticals and Novel Laboratories for $880 million, in a cash-free and debt deal
Eli Lilly to buy Armo BioSciences for $1.6 bn
11 May 2018
US pharmaceutical company Eli Lilly and Co yesterday struck a deal to buy Armo BioSciences Inc for about $1.6 billion in order to strengthen its immuno-oncology portfolio
